Bellerophon Therapeutics, Inc.
BLPHDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600132
Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Bellerophon Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 22 | 2 | −20 |
| Shares | 1.27M | 209.6K | −1.06M (−83.5%) |
| Value | $506.6K | $6.37K | −$500.2K (−98.7%) |
New holders (0)
Institutions that held Bellerophon Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
None.
Sold out (20)
Institutions that held Bellerophon Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Wells Fargo & Company | 180,066 | $71.6K |
| Vanguard Group Inc | 145,810 | $58.0K |
| BlackRock Inc. | 127,723 | $50.8K |
| Two Sigma Investments, LP | 113,911 | $45.3K |
| Geode Capital Management, LLC | 95,656 | $38.3K |
| Renaissance Technologies LLC | 59,499 | $24.0K |
| Citadel Advisors LLC | 42,717 | $17.1K |
| State Street Corp | 30,127 | $12.1K |
| Northern Trust Corp | 30,251 | $12.0K |
| Two Sigma Advisers, LP | 21,500 | $8.55K |
| Susquehanna International Group, LLP | 15,313 | $6.13K |
| Tower Research Capital LLC (TRC) | 7,135 | $2.84K |
| PFS Partners, LLC | 6,000 | $2.39K |
| Group One Trading, L.P. | 2,100 | $840 |
| US Bancorp | 1,221 | $485 |
| Advisor Group Holdings, Inc. | 557 | $221 |
| Qube Research & Technologies Ltd | 52 | $21 |
| Global Wealth Strategies & Associates | 50 | $20 |
| GPS Wealth Strategies Group, LLC | 38 | $15 |
| Morgan Stanley | 33 | $13 |